Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P74
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 27.78% |
| Q3 2025 | 15.62% |
| Q2 2025 | 31.05% |
| Q1 2025 | 17.96% |
| Q4 2024 | 38.01% |
| Q3 2024 | 17.90% |
| Q2 2024 | 47.80% |
| Q1 2024 | 111.18% |
| Q4 2023 | 598.88% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | -75.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | 2734.32% |
| Q1 2022 | 59.47% |
| Q4 2021 | -72.74% |
| Q3 2021 | -94.37% |
| Q2 2021 | -34.14% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |